PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery and Cancer, Imperial College, London, UK.\', \'Eli Lilly and Company, Indianapolis, IN, USA.\', \'Luigi Sacco, Department of Clinical and Biomedical Sciences, University of Milan, Milan, Italy.\', \'BenevolentAI, London, UK.\', \'Unit of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.\', \'Department of Physiology and Pharmacology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.\', \'Infectious Diseases Programme, Immunology Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.\', \'Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore, Singapore.\', \'Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy.\', \'Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.\', \'Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.15252/emmm.202012697
?:doi
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 32473600
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
is ?:relation_isRelatedTo_publication of
?:title
  • Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all